The high yield expansion and megakaryocytic differentiation of human umbilical cord blood CD133+ cells

Cell Journal

Volumn 13, Issue 3, 2011, Pages 173-178

  Zarif, Mahin Nikougoftar ^a,b   Soleimani, Masoud ^a   Abolghasemi, Hassan ^b,c   Amirizade, Naser ^b   Abroun, Saeid ^a   Kaviani, Saeid ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c Baghiyatallah University   (Iran)

Author keywords

Cord blood; Differentiation; Expansion; Megakaryocyte

Indexed keywords

CD133 ANTIGEN; CD135 ANTIGEN; CD61 ANTIGEN; FIBRINOGEN RECEPTOR; STEM CELL FACTOR; THROMBOPOIETIN;

ARTICLE; BLOOD SAMPLING; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DENSITY; CELL DIFFERENTIATION; CELL EXPANSION; CELLULAR DISTRIBUTION; COLONY FORMING UNIT; CYTOKINE PRODUCTION; DNA DETERMINATION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PLOIDY; UMBILICAL CORD BLOOD;

EID: 83455162411     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. van den Oudenrijn S, von dem Borne AE, de Haas M. Differences in megakaryocyte expansion potential between CD34+ stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol. 2000; 28(9): 1054-1061.
2. Heike T, Nakahata T. Ex vivo expansion of hematopoietic stem cells by cytokines. Biochim Biophys Acta. 2002; 1592(3): 313-321. (Pubitemid 35284887)
3. Platzbecker U, Prange-Krex G, Bornhauser M, Koch R, Soucek S, Aikele P, et al. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion. 2001; 41(2): 184-189. (Pubitemid 32220507)
4. Stanevsky A, Goldstein G, Nagler A. Umbilical cord blood transplantation: Pros, cons and beyond. Blood Rev. 2009; 23(5): 199-204.
5. Gluckman E, Locatelli F. Umbilical cord blood transplants. Curr Opin Hematol. 2000; 7(6): 353-357.
6. Bruno S, Gunetti M, Gammaitoni L, Dane A, Cavalloni G, Sanavio F,et al.In vitro and in vivo megakaryocyte differentiation of fresh and ex vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution. Haematologica. 2003; 88(4): 379-387. (Pubitemid 36547123)
7. Zheng C, Yang R, Han Z, Zhou B, Liang L, Lu M. TPO-independent megakaryocytopoiesis. Crit Rev Oncol Hematol. 2008; 65(3): 212-222.
8. Cortin V, Garnier A, Pineault N, Lemieux R, Boyer L, Proulx C. Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. Exp Hematol. 2005; 33(10): 1182-1191. (Pubitemid 41416966)
9. Dimitriou H, Vorgia P, Stiakaki E, Mavroudis D,Markaki EA, Koumantakis E,et al. In vitro proliferative and differentiating characteristics of CD133(+) and CD34(+) cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO), potential implications for hematopoietic cell transplantation. Leuk Res. 2003; 27(12): 1143-1151. (Pubitemid 36960034)
10. Yang M, Li K, Chui CM, Yuen PM, Chan PK, Chuen CK, et al. Expression of interleukin (IL)1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression. Br J Haematol. 2000; 111(1): 371-380.
11. Metcalf D, Carpinelli MR, Hyland C, Mifsud S, Dirago L, Nicola NA, et al. . Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene. Blood. 2005; 105(9): 3480-3487. (Pubitemid 40628189)
12. Kaushansky K, Drachman JG.The molecular and cellular biology of thrombopoietin:the primary regulator of platelet production. Oncogene. 2002; 21(21): 3359-3367. (Pubitemid 34587708)
13. Balduini A, d'Apolito M, Arcelli D, Conti V, Pecci A, Pietra D, et al. Cord blood in vitro expanded CD41 cells: identification of novel components of megakaryocyto poiesis. J Thromb Haemost. 2006; 4(4): 848-860.
14. Fox NE, Priestley G, Papayannopoulou T, Kaushansky K. Thrombopoietin expands hematopoietic stem cells after transplantation. J Clin Invest. 2002; 110(3): 389-394. (Pubitemid 34847971)
15. Kie JH, Yang WI, Lee MK, Kwon TJ, Min YH, Kim HO, et al. Decrease in apoptosis and increase in polyploidization of megakaryocytes by stem cell factor during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin. Stem Cells. 2002; 20(1): 73-79.
16. Proulx C, Boyer L, Hurnanen DR, Lemieux R. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+ enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand. J Hematother Stem Cell Res. 2003; 12(2): 179-188. (Pubitemid 36529569)
17. Ungerer M, Peluso M, Gillitzer A, Massberg S, Heinzmann U, Schulz C, et al. Generation of functional culture- derived platelets from CD34+ progenitor cells to study transgenes in the platelet environment. Circ Res. 2004; 95(5): e36-44.
18. Fock EL, Yan F, Pan S, Chong BH. NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo. Exp Hematol. 2008; 36(1): 78-92. (Pubitemid 350266967)
19. Kashiwakura I, Takahashi K, Monzen S, Nakamura T, Takagaki K. Ex vivo expansions of megakaryocytopoiesis from placental and umbilical cord blood CD34(+) cells in serum-free culture supplemented with proteoglycans extracted from the nasal cartilage of salmon heads and the nasal septum cartilage of whale. Life Sci. 2008; 82(19-20): 1023-1031.
20. Piacibello W, Gammaitoni L, Bruno S, Gunetti M, Fagioli F, Cavalloni G, et al. Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells. J Hematother Stem Cell Res. 2000; 9(6): 945-956. (Pubitemid 32110296)
21. Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H, et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor,Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000; 105(7): 1013-1021. (Pubitemid 30203074)
22. Kuter DJ, Begley CG. Recombinant human thrombopoietin: Basic biology and evaluation of clinical studies. Blood. 2002; 100(10): 3457-3469. (Pubitemid 35303910)
23. Su RJ, Li K, Yang M, Zhang XB, Tsang KS, Fok TF, et al. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood. Bone Marrow Transplant. 2001; 27(10): 1075-1080. (Pubitemid 32591192)
24. Bruno S, Gammaitoni L, Gunetti M, Sanavio F, Fagioli F, Aglietta M, et al. Different growth factor requirements for the ex vivo amplification of transplantable human cord blood cells in a NOD/SCID mouse model. J Biol Regul Homeost Agents. 2001; 15(1): 38-48. (Pubitemid 32492727)
25. Goodarzi A, Kheirandish M, Pourfathollah A, Siadat SD, Pourpak Z.Characterization of megakaryocyte progenitor cells differentiated from umbilical cord blood CD133+ and CD133- cells. Yakhteh. 2007; 9(3): 190-195.
26. Kashiwakura I, Murakami M, Inanami O, Hayase Y, Takahashi TA, Kuwabara M, et al. Effects of amifostine on the proliferation and differentiation of megakaryocytic progenitor cells.Eur J Pharmacol. 2002; 437(1-2): 19-25. (Pubitemid 34178381)
27. Guerriero R, Mattia G, Testa U, Chelucci C, Macioce G, Casella I, et al. Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood. 2001; 97(9): 2587-2595.
28. Schipper LF, Brand A, Reniers N, Melief CJ, Willemze R, Fibbe WE. Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol. 2003; 31(4): 324-330. (Pubitemid 36407609)
29. Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004; 10(1): 64-71. (Pubitemid 38524700)